Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

T cell receptor can be recruited to a subset of plasma membrane rafts, independently of cell signaling and attendantly to raft clustering.

Giurisato E, McIntosh DP, Tassi M, Gamberucci A, Benedetti A.

J Biol Chem. 2003 Feb 28;278(9):6771-8. Epub 2002 Dec 22.

2.

Diacylglycerol activates the influx of extracellular cations in T-lymphocytes independently of intracellular calcium-store depletion and possibly involving endogenous TRP6 gene products.

Gamberucci A, Giurisato E, Pizzo P, Tassi M, Giunti R, McIntosh DP, Benedetti A.

Biochem J. 2002 May 15;364(Pt 1):245-54. Erratum in: Biochem J 2002 Sep 15;366(Pt 3):999.

3.
4.

Caveolae require intact VAMP for targeted transport in vascular endothelium.

McIntosh DP, Schnitzer JE.

Am J Physiol. 1999 Dec;277(6):H2222-32. doi: 10.1152/ajpheart.1999.277.6.H2222.

PMID:
10600840
7.

Pharmacokinetics and tissue distribution of cisplatin and conjugates of cisplatin with carboxymethyldextran and A5B7 monoclonal antibody in CD1 mice.

McIntosh DP, Cooke RJ, McLachlan AJ, Daley-Yates PT, Rowland M.

J Pharm Sci. 1997 Dec;86(12):1478-83.

PMID:
9423164
8.

Role of GTP hydrolysis in fission of caveolae directly from plasma membranes.

Schnitzer JE, Oh P, McIntosh DP.

Science. 1996 Oct 11;274(5285):239-42. Erratum in: Science 1996 Nov 15;274(5290):1069.

PMID:
8824187
9.

Separation of caveolae from associated microdomains of GPI-anchored proteins.

Schnitzer JE, McIntosh DP, Dvorak AM, Liu J, Oh P.

Science. 1995 Sep 8;269(5229):1435-9.

PMID:
7660128
10.
11.

Antibody to a 63 kilodalton insect protein in ankylosing spondylitis.

Brand SR, Worthington J, McIntosh DP, Bernstein RM.

Ann Rheum Dis. 1992 Mar;51(3):334-9.

12.

The effect of ricin B chain on the intracellular trafficking of an A chain immunotoxin.

Timar J, McIntosh DP, Henry R, Cumber AJ, Parnell GD, Davies AJ.

Br J Cancer. 1991 Oct;64(4):655-62.

13.

An ineffective monoclonal antibody-ricin A chain conjugate is converted to a tumouricidal agent in vivo by subsequent systemic administration of ricin B chain.

Eccles SA, McIntosh DP, Purvies HP, Cumber AJ, Parnell GD, Forrester JA, Styles JM, Dean CJ.

Cancer Immunol Immunother. 1987;24(1):37-41.

PMID:
3493071
14.
15.

Transfer of ricin toxicity by spleen cells.

McIntosh DP, Edwards DC, Davies AJ.

Toxicon. 1984;22(2):293-9.

PMID:
6729844
16.

Delivery of ricin and abrin A-chains to human carcinoma cells in culture following covalent linkage to monoclonal antibody LICR-LOND-Fib 75.

Forrester JA, McIntosh DP, Cumber AJ, Parnell GD, Ross WC.

Cancer Drug Deliv. 1984 Fall;1(4):283-92.

PMID:
6544125
17.

Antibody-toxin conjugates: a new approach to cancer therapy.

McIntosh DP.

Adv Biotechnol Processes. 1984;3:111-39. Review. No abstract available.

PMID:
6399840
18.

Ricin B chain converts a non-cytotoxic antibody-ricin A chain conjugate into a potent and specific cytotoxic agent.

McIntosh DP, Edwards DC, Cumber AJ, Parnell GD, Dean CJ, Ross WC, Forrester JA.

FEBS Lett. 1983 Nov 28;164(1):17-20.

19.

Liposome-mediated delivery of ribosome inactivating proteins to cells in vitro.

McIntosh DP, Heath TD.

Biochim Biophys Acta. 1982 Sep 9;690(2):224-30.

PMID:
6982072

Supplemental Content

Loading ...
Support Center